Prescribing patterns and preferences for moderate-to-severe pediatric (<12 years of age) atopic dermatitis: A survey of Canadian practitioners
Saved in:
Main Authors: | Michele L. Ramien, MDCM, MSc (Author), Vipul Jain, MD (Author), James Bergman, MD (Author), Danielle Marcoux, MD (Author), Irene Lara-Corrales, MDCM, MSc (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis
by: Mahreen Ameen, et al.
Published: (2024) -
Treatment preferences among patients with mild-to-moderate atopic dermatitis
by: Kelley Myers, et al.
Published: (2023) -
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023) -
Oxidative stress as a treatment target in atopic dermatitis: The role of furfuryl palmitate in mild-to-moderate atopic dermatitis
by: Adelaide A. Hebert, MD
Published: (2020) -
Therapeutic education in atopic dermatitis: A position paper from the International Eczema CouncilCapsule Summary
by: Lawrence F. Eichenfield, MD, et al.
Published: (2021)